To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Sphingosine 1-phosphate receptor 1 (S1PR1; S1P1; EDG1)

Autoimmune disease

INDICATION: Multiple sclerosis (MS); rheumatoid arthritis (RA)

In vitro, rat and mouse studies identified an S1PR1 agonist that could help

Read the full 207 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE